|
ISPDC 2012 - Kyoto: 3rd Annual Symposium |
|
|
|
|
Written by Administrator
|
|
Friday, 20 January 2012 09:12 |
|

The 3rd ISPDC Annual Symposium in Kyoto on the 12th and 13th of October 2012.
Symposium venue will be: Kyoto Prefectural University of Medicine, Kyoto city.
To read more, click here ...
|
|
|
Three PhD scholarships – Ion Transport Proteins in Control of Cancer Cell Behavior (IonTraC) |
|
|
Written by Stine Falsig Pedersen, Ph.D.
|
|
Wednesday, 08 February 2012 16:31 |
|
IonTraC is a Marie Curie Initial Training Network and a special focus will be on pancreatic cancer. The IonTraC group is a European research consortium funded within the Marie Curie Initial Training Network action. It is composed of 11 research units (9 academic and 2 industrial/SME partners) with long-standing, complementary expertise in transport physiology, biophysics, pathology, cell biology, pharmacology, optical imaging, experimental and clinical oncology. The overall aim of the IonTraC project is to comprehensively test the hypotheses that proteins involved in ion transport constitute novel diagnostic/therapeutic targets for pancreatic ductal adenocarcinoma (PDAC). IonTraC will provide structured PhD program with extensive focus on mobility and collaboration. The three PhD positions (each 3 years of duration) are affiliated with sections of Molecular Integrative Physiology and Cell and Developmental Biology at the Department of Bi-ology, University of Copenhagen, and groups lead by Ivana Novak, Stine F. Pedersen and Else K. Hoffmann.
Read more ...
|
|
ISPDC 2011 Nice Symposium Report |
|
|
|
Written by Administrator
|
|
Tuesday, 03 January 2012 13:23 |

The second International meeting of the International Society for Proton Dynamics in Cancer (ISPDC) was held in Nice, November 18-19, 2011. ISPDC is a young and dynamic society that was originally initiated by clinicians (Stefano Fais, Italy and Salvador Harguindey, Spain). The society’s objective is to assemble and integrate international scientists with an interest in the control of intracellular pH (pHi) as a new clinical approach for the treatment of highly proliferative, aggressive, and invasive cancers. Indeed, a defining characteristic of these types of cancers (triple negative breast cancers, glioblastomas, and pancreatic cancers for example) is the presence of a glycolytic metabolism in hypoxic surroundings that requires a major dependence on mechanisms to regulate intracellular pH.
|
|
International Society for Proton Dynamics in Cancer - ISPDC |
|
|
|
|
Tuesday, 24 November 2009 00:00 |
|
.jpg)
The objectives of the International Society for Proton Dynamics in Cancer are to improve communication and to foster collaborative activities and research programs between European and non European scientists engaged in acidity, alkalinity, pH changes and proton dynamics in cancer research.
|
|
|